1. Home
  2. DOMH vs PBM Comparison

DOMH vs PBM Comparison

Compare DOMH & PBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DOMH
  • PBM
  • Stock Information
  • Founded
  • DOMH 1967
  • PBM 1994
  • Country
  • DOMH United States
  • PBM Canada
  • Employees
  • DOMH N/A
  • PBM N/A
  • Industry
  • DOMH Biotechnology: Pharmaceutical Preparations
  • PBM
  • Sector
  • DOMH Health Care
  • PBM
  • Exchange
  • DOMH Nasdaq
  • PBM NYSE
  • Market Cap
  • DOMH 8.8M
  • PBM 5.3M
  • IPO Year
  • DOMH N/A
  • PBM N/A
  • Fundamental
  • Price
  • DOMH $3.02
  • PBM $1.37
  • Analyst Decision
  • DOMH
  • PBM
  • Analyst Count
  • DOMH 0
  • PBM 0
  • Target Price
  • DOMH N/A
  • PBM N/A
  • AVG Volume (30 Days)
  • DOMH 427.5K
  • PBM 526.0K
  • Earning Date
  • DOMH 03-31-2025
  • PBM 02-02-2025
  • Dividend Yield
  • DOMH N/A
  • PBM N/A
  • EPS Growth
  • DOMH N/A
  • PBM N/A
  • EPS
  • DOMH N/A
  • PBM N/A
  • Revenue
  • DOMH $12,589,000.00
  • PBM N/A
  • Revenue This Year
  • DOMH N/A
  • PBM N/A
  • Revenue Next Year
  • DOMH N/A
  • PBM N/A
  • P/E Ratio
  • DOMH N/A
  • PBM N/A
  • Revenue Growth
  • DOMH 1117.50
  • PBM N/A
  • 52 Week Low
  • DOMH $0.83
  • PBM $1.21
  • 52 Week High
  • DOMH $4.35
  • PBM $323.25
  • Technical
  • Relative Strength Index (RSI)
  • DOMH 65.22
  • PBM 37.76
  • Support Level
  • DOMH $2.86
  • PBM $1.21
  • Resistance Level
  • DOMH $4.35
  • PBM $1.59
  • Average True Range (ATR)
  • DOMH 0.52
  • PBM 0.24
  • MACD
  • DOMH 0.14
  • PBM 0.03
  • Stochastic Oscillator
  • DOMH 53.19
  • PBM 17.53

About DOMH Dominari Holdings Inc.

Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company's oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.

About PBM PSYENCE BIOMEDICAL LTD

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Share on Social Networks: